AlphaHunt
Healthcare

BMY Stock Analysis

Bristol-Myers Squibb Company · current price $55.30 (-1.14% today)

★★ Below Avg 49/ Alpha Score
Risk is rising; momentum is fading or fundamentals are weakening. Multiple risk indicators are firing.
LAST EARNINGS Bristol-Myers Squibb Company (BMY)

Latest earnings

EPS
$1.46 vs $1.10 est · +0.3% vs estimate BEAT
Revenue
$11.49B · -6.4% YoY
Stock reaction (1M)
-3.5%
Beat streak
4 of last 4 quarters

Key metrics

Alpha Score
49/100
Grade
D
Rev Growth YoY
+2.6%
30-day Momentum
-3.5%
Forward P/E
15.5×
Analyst Target
$63.08
Implied Upside
+14.1%

Similar stocks in Healthcare

BIIB WST LLY WAT MRNA DGX

View all Healthcare stocks →

BMY — frequently asked

What is BMY's Alpha Score?

Bristol-Myers Squibb Company (BMY) currently has a TickerMover Alpha Score of 49/100, rated ★★ Below Avg. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Bristol-Myers Squibb Company (BMY) a buy?

TickerMover does not give buy or sell recommendations. BMY scores 49/100 (★★ Below Avg) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is BMY's score updated?

BMY's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for BMY →
TickerMover is a research tool, not financial advice. Alpha Score is a composite signal — always do your own research before investing.
Last updated automatically every 5 minutes during US market hours.
Questions? support@tickermover.com